Dr. John Cush RheumNow
4 years 7 months ago
Join Dr. Ronan Kavanagh for an incredible STEP Session at #RNL2022, where he will discuss The Jazz of Rheumatology.
Register today!
https://t.co/hMzdpN327q https://t.co/uHYC9VV1kp
Dr. John Cush RheumNow
4 years 7 months ago
Round up of last week's QD Clinics:
-Steroid Weaning
-Diagnosing Neuropsychiatric Lupus
- Not the Same Ol’ Lecture
- Your Next Follow-up Visit is When?
QD Clinic is sponsored by RheumNow Live
https://t.co/9U1wcbIMs4 https://t.co/HjyyGtbe4r
My uncle is going through medical hell. As a committed iatrophobic (fear of doctors), any mention of phlebotomy, tests, needles or a clinic visit evokes flop-sweat. Since being slapped with a cancer diagnosis, he has overcome a lot, and much to my surprise has bravely done so.
When I asked how he has adapted so well to the medical onslaught he now leans into, his answer was quick and poignant.
Dr. John Cush RheumNow
4 years 7 months ago
UK Biobank case control study of 15 871 pts with Gout and COVID. Gout associated with diagnosis of COVID-19 (OR 1·20; CI 1·11–1·29) but not with risk of COVID-19-related death in the cohort of patients diagnosed with COVID-19 (1·20, 0·96–1·51). https://t.co/dN5YnIqhzD
Dr. John Cush RheumNow
4 years 7 months ago
Should we use colchicine in COVID-19? Mainly mixed results; not likely effective in sick hospitalized patients but may have utility in early infections https://t.co/wecWjSIbEG
Dr. John Cush RheumNow
4 years 7 months ago
ICYMI: NEJM study of ~2000 persons showed that prior PCR proven SARS-CoV-2 infection was effective at preventing Symptomatic Reinfection against alpha variant (90.2%), beta ( 85.7%), delta (92%), but not omicron variant (56%). https://t.co/UkvDUH6alK
Dr. John Cush RheumNow
4 years 7 months ago
ICYMI: Retrospective study of 179 antiphospholipid syndr pts, looked at noncriteria findings- their presence incr relapse rates (59% vs 34%;p=0.018) triple positivity & need for Rx. (cytopenias, APS nephropathy, livedo, CNS, Libman Sachs endocarditis) https://t.co/i7UItlDcHd
Dr. John Cush RheumNow
4 years 7 months ago
ICYMI: Women Heroes in Rheum:
- Barbara Ansell - JIA
- Nanna Svartz-SSZ
- Gertrude Elion - Nobel Prize for allopurinol, AZA
- Tsai-Fan Yu - gout Rx
- Mary Betty Stevens - lupus/vasculitis
- Marian Ropes - 1st F ARA president
- Fionula Brennan-TNFi
& more
https://t.co/0kxrXo5fr3 https://t.co/QfCDxkfYRi
Dr. John Cush RheumNow
4 years 7 months ago
ICYMI: Approximately 61% of patients with rheumatoid arthritis or psoriatic arthritis who use methotrexate report side effects following weekly dosing, including fatigue and nausea, according to data published in Rheumatology and Therapy https://t.co/65OMw9A96h
Dr. John Cush RheumNow
4 years 7 months ago
Data from 2 phase III studies of psoriatic arthritis using tofacitinib, adalimumab shows that a significant meaningful clinical response is achieved in 29-53 days -- why then are we not making go vs no-go decisions with modern biologics at 6-8 weeks? https://t.co/F56P9c3Rb5
Dr. John Cush RheumNow
4 years 7 months ago
CARRA Registry looked at TNFi use in JIA and found a nearly 3 fold increased risk of psoriasis. 8225 pts w/ 3.9 yrs of F/U. 54% recv TNFi; the aHR of new onset of psoriasis after TNFi exposure was 2.93 (2.15 to 3.98). MTX had lower risk (HR 0.45) https://t.co/Z6qvlS26M9
Dr. John Cush RheumNow
4 years 7 months ago
Osteoarthritis Initiative study looked at Hand OA. Among 3588 participants, 41% had hand OA by xray and 12.4 % by Sxs. Over 4 yrs, 27.3 % showed Xray OA progression. More in women (DIPs)>men (MCPs), but less in blacks https://t.co/WRZYcL7zFH
Interesting reports this week about dementia, who gets hand OA and a great list of women Heroes and Pillars of Rheumatology. Tune in as Dr. Jack Cush reviews the news and journal articles from this past week in RheumNow.com.
